Le Lézard
Classified in: Environment, Transportation, Business
Subjects: FNC, PDT, ENI, CFG

Brampton Electric Bus Project Grows Pan-Canadian Initiative


NRCan funding facilitates continued expansion of standardized and interoperable electric bus transportation infrastructure across Canada.

BRAMPTON, ON, July 29, 2019 /CNW/ - As part of the continued progress of the Pan-Canadian Electric Bus Demonstration and Integration Trial, CUTRIC is proud to announce the commitment of over $8 million from NRCan to Brampton Transit. This funding will ensure the success of the project with the integrated inclusion of 8 standardized electric buses and 4 interoperable overhead high-power chargers. 

Canadian Urban Transit Research & Innovation Consortium (CUTRIC) (CNW Group/Canadian Urban Transit Research & Innovation Consortium (CUTRIC))

The Pan-Canadian Electric Bus Demonstration and Integration Trial: Phase I was launched at TransLink in Vancouver in April 2018 as part of a nationally coordinated effort to advance zero emissions transit technology, spearheaded by the Canadian Urban Transit Research and Innovation Consortium (CUTRIC).

CUTRIC brought together manufacturers, transit agencies, utilities, funding partners, research teams, and technology development capacities for the launch announcement that saw a demonstration trial through the community. 

Brampton Transit, the City of Brampton, York Region Transit, and the Regional Municipality of York join Translink and the City of Vancouver as sites for the trial, with Brampton Transit having spearheaded the trial planning process back in 2016.

"The growth of the Pan-Canadian Electric Bus Demonstration and Integration Trial makes Canada a world leader in electric and zero-emissions transportation technologies by shifting the entire industry towards interoperability and standardization. This is good news for taxpayers and great news for transit riders.  This project is generating new low-carbon technology jobs and attracting investments by major companies into Canada's technology development sector."
?Josipa Petrunic, CEO, CUTRIC.

"The Pan-Canadian Electric Bus Demonstration and Integration Trial is a unique partnership model involving multiple levels of government, bus manufacturers, system integrators and funding partners collaborating in an unprecedented way on breakthrough technology to improve the environment. We are proud to be the lead transit agency in the planning and execution of this trial in partnership with CUTRIC. This project positions the City of Brampton to establish the largest single global deployment of standardized and fully interoperable battery-electric buses and high-powered overhead on-route charging systems."
?Alex Milojevic, General Manager of Brampton Transit.

Brampton Transit is working with two Canadian transit vehicle manufacturers (New Flyer Industries Canada of Winnipeg, Manitoba and Nova Bus, of St. Eustache, Quebec) and two charging station manufacturers (ABB Group and Siemens Canada, located in Montreal and Oakville respectively) to deploy electric buses and electric charging stations that utilize an open protocol known as the OppCharge protocol?first developed by Siemens and Volvo Bus Corporation.

CUTRIC will be collecting data from all of the electric buses and electric chargers in operation as part of this project in order to build a Canadian E-Bus Big Data Trust for Canadian municipalities in 2020.

CUTRIC is a member-based innovation consortium that partners stakeholders in industry, transit and academia to develop the next-generation of low-carbon smart mobility technologies. Its vision is to make Canada a global leader in low-carbon smart mobility technology innovation. Its mandate is to catalyze innovation in transportation, create jobs in doing so, and radically reduce emissions from transportation. 

Partner companies that are invested in this project include: 

www.cutric-crituc.org
Twitter: @cutric_crituc

SOURCE Canadian Urban Transit Research & Innovation Consortium (CUTRIC)


These press releases may also interest you

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:39
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...



News published on and distributed by: